Prospective comparative study of the safety and effectiveness of ginger for the treatment of XXXX and @entity391 in pregnancy.

@entity1 @entity391 @entity390 @entity600
OBJECTIVES: The primary objective of our study was to examine the safety and the secondary objective was to examine the effectiveness of ginger for @entity390 and @entity391 (NVP). STUDY DESIGN: Pregnant @entity1 who called the Motherisk Program who were taking ginger during the first trimester of pregnancy were enrolled in the study. The @entity1 were compared with a group of @entity1 who were exposed to nonteratogenic drugs that were not antiemetic medications. The @entity1 were followed up to ascertain the outcome of the pregnancy and the health of their @entity1 . They were also asked on a scale of 0 to 10 how effective the ginger was for their symptoms of NVP. RESULTS: We were able to ascertain the outcome of 187 pregnancies. There were 181 live births, 2 stillbirths, 3 spontaneous abortions, and 1 therapeutic abortion. The mean birth weight was 3542+/-543 g, the mean gestational age was 39+/-2 weeks, and there were three major @entity600 . There were no statistical differences in the outcomes between the ginger group and the comparison group with the exception of more @entity1 weighing less than 2500 g in the comparison group (12 vs 3, P < or =.001). There were a total of 66 completed effectiveness scores with the mean score of 3.3+/-2.9 SD. CONCLUSION: These results suggest that ginger does not appear to increase the rates of major @entity600 above the baseline rate of 1% to 3% and that it has a mild effect in the treatment of NVP.
